Sanofi (SNY)
NASDAQ: SNY
· Real-Time Price · USD
49.77
0.73 (1.49%)
At close: Aug 15, 2025, 3:59 PM
49.75
-0.05%
After-hours: Aug 15, 2025, 07:35 PM EDT
Sanofi Cash Flow Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | n/a | 683M | 2.81B | 1.11B | 1.13B | 1.97B | 2.52B | 3.43B | 2B | 5.19B | 2.08B | 3.18B | 2.01B | 3.45B | 2.32B | 2.78B | 1.57B |
Depreciation & Amortization | n/a | n/a | n/a | 1.46B | n/a | 2.99B | n/a | 1.86B | n/a | 1.61B | n/a | 1.83B | n/a | 1.63B | n/a | 1.73B | n/a |
Stock-Based Compensation | n/a | n/a | n/a | 173M | n/a | 283M | n/a | 160M | n/a | 245M | n/a | 144M | n/a | 244M | n/a | 134M | n/a |
Other Working Capital | n/a | n/a | n/a | -2.72B | n/a | 1.53B | n/a | 73M | n/a | 594M | n/a | -49M | n/a | 436M | n/a | 694M | n/a |
Other Non-Cash Items | 2.09B | -683M | -2.81B | 2.1B | -1.13B | 6.6B | -2.52B | 4.15B | -2B | 3.22B | -2.08B | 4.91B | -2.01B | 2.86B | -2.32B | 3.47B | -1.57B |
Deferred Income Tax | n/a | n/a | n/a | -780M | n/a | -524M | n/a | -446M | n/a | -174M | n/a | -404M | n/a | -222M | n/a | -134M | n/a |
Change in Working Capital | n/a | n/a | n/a | -2.64B | n/a | 1.58B | n/a | -819M | n/a | 335M | n/a | -1.04B | n/a | 874M | n/a | 535M | n/a |
Operating Cash Flow | 2.09B | n/a | n/a | 1.42B | n/a | 6.7B | n/a | 3.56B | n/a | 6.7B | n/a | 3.83B | n/a | 5.77B | n/a | 4.75B | n/a |
Capital Expenditures | n/a | n/a | n/a | -1.89B | n/a | -2.11B | n/a | -1.15B | n/a | -1.2B | n/a | -1.02B | n/a | -1.09B | n/a | -1.02B | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 437M | n/a | 575M | n/a | 1.06B | n/a | -433M | n/a | -3.65B | n/a | -1.22B | n/a |
Purchase of Investments | n/a | n/a | n/a | -2.09B | n/a | -1.48B | n/a | -2.52B | n/a | -378M | n/a | -110M | n/a | -240M | n/a | -71M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 27M | n/a | 15M | n/a | -101M | n/a | 101M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -776M | n/a | n/a | 607M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29M | n/a | -29M | n/a |
Investing Cash Flow | -776M | n/a | n/a | -3.41B | n/a | -3.13B | n/a | -3.08B | n/a | -616M | n/a | -1.46B | n/a | -4.96B | n/a | -2.34B | n/a |
Debt Repayment | n/a | n/a | n/a | 5.25B | n/a | -2.62B | n/a | -249M | n/a | -43M | n/a | -911M | n/a | -310M | n/a | -2.34B | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -302M | n/a | -230M | n/a | -363M | n/a | -137M | n/a | -360M | n/a | -242M | n/a | -140M | n/a |
Dividend Paid | n/a | n/a | n/a | -4.7B | n/a | n/a | n/a | -4.45B | n/a | n/a | n/a | -4.17B | n/a | n/a | n/a | -4.01B | n/a |
Other Financial Acitivies | -592M | n/a | n/a | -175M | n/a | -150M | n/a | -176M | n/a | -184M | n/a | -206M | n/a | -51M | n/a | -147M | n/a |
Financial Cash Flow | -592M | n/a | n/a | 89M | n/a | -2.84B | n/a | -5.21B | n/a | -216M | n/a | -5.61B | n/a | -440M | n/a | -6.62B | n/a |
Net Cash Flow | 550M | n/a | n/a | -1.92B | n/a | 717M | n/a | -4.74B | n/a | 5.84B | n/a | -3.2B | n/a | 376M | n/a | -4.19B | n/a |
Free Cash Flow | 2.09B | n/a | n/a | -504M | n/a | 4.59B | n/a | 2.42B | n/a | 5.5B | n/a | 2.81B | n/a | 4.67B | n/a | 3.74B | n/a |